Mohamed M. Qureshi

Decreased alpha-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson's disease.

T. Tokuda, J. Locascio, D. Allsop, 2006, Biochemical and biophysical research communications.

Decreased α-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson’s disease.

T. Tokuda, J. Locascio, D. Allsop, 2006 .

Cerebrospinal fluid Tau/α‐synuclein ratio in Parkinson's disease and degenerative dementias

P. Calabresi, M. Onofrj, L. Bonanni, 2011, Movement disorders : official journal of the Movement Disorder Society.

Detection of elevated levels of α-synuclein oligomers in CSF from patients with Parkinson disease

T. Tokuda, M. Nakagawa, A. Tamaoka, 2010, Neurology.

α-Synuclein Levels in Blood Plasma from LRRK2 Mutation Carriers

A. Gorostidi, J. Ruiz‐Martinez, A. L. de Munain, 2012, PloS one.

Designing peptide inhibitors for oligomerization and toxicity of Alzheimer's beta-amyloid peptide.

B. Austen, D. Allsop, O. El-Agnaf, 2008, Biochemistry.